MarketWatch.com - Top Stories

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.

Feb 25, 2025 - 16:21
 0
Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up
The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
Read More

Tags:

Previous Article

Warren Buffett Just Made a Surprise Move. Here's What It Could Mean For the Markets

Next Article

Hims & Hers will stop selling some weight-loss drugs — and its stock plummeted

Related Posts

Coinbase says crypto is seeing ‘dawn of a new era.’ But does Wall Street share its optimism?

Coinbase says crypto is seeing ‘dawn of a new era.’ But...

Feb 14, 2025  0

‘Trump trades’ like the dollar and bitcoin are stalling, while Chinese stocks are racing ahead

‘Trump trades’ like the dollar and bitcoin are stalling...

Feb 16, 2025  0

The stock market just won’t crack. Bulls say it’s time for a breakout to new highs.

The stock market just won’t crack. Bulls say it’s time ...

Feb 15, 2025  0